TransCode Therapeutics
RNAZ
RNAZ
0 hedge funds and large institutions have $3.14M invested in TransCode Therapeutics in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
–
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$3.23M | |
| 2 | -$762K | |
| 3 | -$751K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$508K |
| 5 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$224K |